Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Shares Issued (2018 - 2025)

TransMedics (TMDX) has 8 years of Shares Issued data on record, last reported at $10.5 million in Q4 2025.

  • For Q4 2025, Shares Issued rose 159.76% year-over-year to $10.5 million; the TTM value through Dec 2025 reached $13.7 million, up 566.96%, while the annual FY2025 figure was $13.7 million, 566.96% up from the prior year.
  • Shares Issued reached $10.5 million in Q4 2025 per TMDX's latest filing, up from -$5.6 million in the prior quarter.
  • Across five years, Shares Issued topped out at $19.0 million in Q3 2024 and bottomed at -$17.6 million in Q4 2024.
  • Average Shares Issued over 5 years is $982777.8, with a median of $304000.0 recorded in 2021.
  • Peak YoY movement for Shares Issued: tumbled 436.67% in 2021, then soared 6824.29% in 2023.
  • A 5-year view of Shares Issued shows it stood at -$510000.0 in 2021, then skyrocketed by 113.73% to $70000.0 in 2022, then tumbled by 6208.57% to -$4.3 million in 2023, then plummeted by 310.8% to -$17.6 million in 2024, then skyrocketed by 159.76% to $10.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $10.5 million in Q4 2025, -$5.6 million in Q3 2025, and $7.5 million in Q2 2025.